Director at DXP Enterprises (DXPE) receives 648-share stock grant at $165.90

Rhea-AI Filing Summary

Hoffman Karen reported acquisition or exercise transactions in this Form 4 filing.

DXP Enterprises Inc. director Karen Hoffman received a grant of 648 shares of DXP Common Stock, recorded at a price of $165.90 per share. This is a stock award rather than an open-market purchase. After the grant, she directly holds 5,435 shares. The grant will fully vest one year from the July 1, 2026 grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hoffman Karen

Role null

Type	Security	Shares	Price	Value
Grant/Award	DXP Common Stock	648	$165.90	$108K

Holdings After Transaction: DXP Common Stock — 5,435 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 648 shares Grant price per share: $165.90 per share Shares held after grant: 5,435 shares

3 metrics

Shares granted 648 shares Director equity grant on July 1, 2026

Grant price per share $165.90 per share Recorded value for DXP Common Stock grant

Shares held after grant 5,435 shares Direct holdings following reported transaction

Key Terms

Grant, award, or other acquisition, DXP Common Stock, vest

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

DXP Common Stock financial

"security_title: DXP Common Stock"

vest financial

"provide for full vesting one year from the date of grant"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/08/2026 - 08:04 PM Accepted by SEC EDGAR 07/08/2026 - 08:03 PM Learn about SEC filing dates

FAQ

What insider transaction did DXP Enterprises (DXPE) director Karen Hoffman report?

Director Karen Hoffman reported receiving a grant of 648 shares of DXP Common Stock. The filing classifies this as a grant, award, or other acquisition, not an open-market purchase or sale, and increases her directly held position in the company.

At what price was Karen Hoffman’s DXP Enterprises (DXPE) stock grant recorded?

The 648-share grant to Karen Hoffman was recorded at $165.90 per share. This price reflects the value used in the Form 4 disclosure and helps indicate the approximate worth of the equity compensation at the time of grant.

How many DXP Enterprises (DXPE) shares does Karen Hoffman hold after the grant?

Following the 648-share grant, Karen Hoffman directly holds 5,435 DXP Common Stock shares. This total, stated in the Form 4, represents her direct ownership position after the reported equity award transaction.

When do Karen Hoffman’s DXP Enterprises (DXPE) granted shares vest?

The footnote explains that the 648-share grant to Karen Hoffman vests fully one year from the grant date. With a grant date of July 1, 2026, the award is scheduled to become fully vested on July 1, 2027, subject to its stated terms.

Was Karen Hoffman’s DXP Enterprises (DXPE) transaction an open-market buy or sell?

No, the transaction was not an open-market trade. The Form 4 uses transaction code “A” and describes it as a grant, award, or other acquisition, indicating equity compensation rather than a discretionary market purchase or sale.

What type of security did Karen Hoffman receive from DXP Enterprises (DXPE)?

Karen Hoffman received DXP Common Stock as part of her director compensation. The Form 4 identifies the security title as DXP Common Stock, confirming it is standard equity rather than a derivative or option-based instrument.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoffman Karen

(Last) (First) (Middle)

5301 HOLLISTER ST

(Street)

HOUSTON TEXAS 77040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DXP ENTERPRISES INC [ DXPE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
DXP Common Stock	07/07/2026		A		648(1)	A	$165.9	5,435	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The term of the grant provide for full vesting one year from the date of grant. [Grant date July 1, 2026 - 648 shares]

Remarks:

	/s/ Karen Hoffman Morris	07/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)